3
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Is the Combination of 5-Fluorouracil and Folinic Acid Effective in Advanced Gastric Carcinoma? Results of a pilot study and review of the literature

, , &
Pages 417-422 | Published online: 15 Jul 2016

References

  • Cancer Facts and Figures, 1984. American Cancer Society 1983.
  • MacDonald JS, Gunderson LL, Cohn I JR. Cancer of the stomach. In: De Vita VT, Hellman S, Rosenberg SA (eds): Cancer Principles and Practice of Oncology. J.B. Lippincott Company: Philadelphia, 1st edition, 1982: 534–562.
  • MacDonald JS, Schein PS, Woolley PV et al. 5-fluorouracil, mitomycin C and adriamycin (FAM): A new combination chemotherapy program for advanced gastric carcinoma. Ann Intern Med 1980; 93: 533–536.
  • Klein HO. Long-term results with FAMTX (5-fluorour-acil, adriamycin, methotrexate) in advanced gastric cancer. Cancer Res. 1989; 9: 1025–1026.
  • Wils JA, Klein HO, Wagener DJ Th et al. Sequential high-dose methotrexate and fluorouracil combined with doxorubicin. A step ahead in the treatment of advanced gastric: A trial of the EORTC of Cancer Gastrointestinal Tract Cooperative Study. J Clin Oncol 1991; 9: 827–831.
  • Evans RM, Laskin JD, Hakala MT. Effect of excess folates and deoxyinosine on the activity and site of action of 5-fluorouracil. Cancer Res 1981; 41: 3288–3295.
  • Madajewicz S, Petrelli N, Rustum YM, et al. A phase I-II trial of high dose calcium Ieucovorin and 5-fluorouracil in advanced colorectal carcinoma. Cancer Res 1984; 44: 4667–4669.
  • WHO. Handbook for reporting results of cancer treatment. WHO Offset publication nr 48. World Health Organization: Geneva, Switzerland 1979.
  • Erlichman C, Fine S, Wong A, et al. A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma. J Clin Oncol 1988; 6: 469–495.
  • Petrelli N, Douglass HO Js, Herrera L, et al. The modulation of fluorouracil with Ieucovorin in metastatic colorectal carcinoma: A prospective randomized phase III trial. J Clin Oncol 1989; 7: 1419–1426.
  • Cullinan SA, Moertel CG, Fleming TR, et al. A comparison of three chemotherapeutic regimens in the treatment of advances pancreatic and gastric carcinoma. JAMA 1985; 253: 2061–2067.
  • Arbuck SG, Douglass HO, Trave F, et al. A phase II trial of 5-fluorouracil and high-dose intravenous leucovorin in gastric carcinoma. J Clin Oncol 1987; 5: 1150–1156.
  • Machover D, Goldschmidt E, Chollet P, et al. Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid. J Clin Oncol 1986; 4: 685–696.
  • Berenberg JL, Goodman PJ, Oishi N, et al. 5-fluorouracil and folinic acid: for the treatment of metastatic gastric cancer. Proc Am Soc Clin Oncol 1989; 8: 392 (abstr).
  • Cassano A, Astone A, Pietrantonio F, et al. Folinic acid and 5-fluorouracil in advanced gastric adenocarcinoma. Proc ECCO 6, Eur J Cancer 1991; 27: (suppl 2) 454 (abstr).
  • Highley M, Hill M, Ziras N, et al. High dose folinic acid and 5-fluorouracil in advanced gastrointestinal malignancy. Proc. ECCO 6, Eur J Cancer 1991; 27: (suppl 2) 446 (abstr).
  • Rubin J, Gallagher J, Schutt A, et al. Phase II trial of 5-fluorouracil and leukovorin in patients with metastatic gastric or pancreatic carcinomas. Proc Am Soc Clin Oncol 1992; 11: 496 (abstr).
  • Jager-Arand E, Bernhard H, Klein O, et al. Combination 5-fluorouracil, folinic acid and a-Interferon 2B in advanced gastric cancer. Proc Am Soc Clin Oncol 1993; 12: 559 (abstr).
  • Cervantes A, Villar-Grimalt A, Abad A, et al. 5-fluorouracil, folinic acid, epidoxorubin and cisplatin (FLEP), combination chemotherapy in advanced measurable gastric cancer. A phase II trial of the Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD). Ann Oncol 1993; 4: 753–757.
  • Arbuck SG, Douglas HO, Nava H et al. A Phase II trial of 5-FU, adriamycin, mitomycin-c and leucovorin (FAMCF) in advanced gastric carcinoma. Proc Am Soc Clin Oncol 1989; 8: 402 (abstr).
  • Colucci G, Maiello E, Valori V, et al. A randomized study with 5-FU and folinic acid alone or with epirubicin in advanced gastric carcinoma. Proc. ECCO-6, Eur J Cancer 1991; 27 (suppl 2) 456 (abstr).
  • Taal BG, Teller FGM, ten Bokkel Huinink WW, et al. Etoposide, leucovorin, 5-fluorouracil (ELF) combination chemotherapy for advanced gastric cancer: Experience with two treatment schedules incorporating intravenous or oral etoposide. Ann Oncol 1994; 5: 90–92.
  • Zironi S, Cocconi G, Bella M et al. A prospective randomized trial comparing FAM combination with PELF combination in advanced gastric carcinoma. Ann Oncol 1992; 3 (suppl 5): 13.
  • Louvet C, De Gramont A, Beerblock K et al. Hydroxyurea, leucovorin, 5 FU and cisplatin (HLFP regimen): High response rate and low toxicity in advanced gastric cancer. Proc Am Soc Clin Oncol 1994; 13: 576 (abstr).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.